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ABSTRACT 
In last few decades, though significant progress has been made in the treatment and control strategies of tubercular infections by 
introducing new diagnostic and monitoring tools and combination therapy, it still continues to be severe problem. The need of study 
was only because of there are many drugs in market to treat infection but most of the drugs are showing resistance because of the 
same it is difficult to treat the infection. In this study we chosen coumarin nucleus for study. Thus with the aim of developing novel 
molecule with improved potency for treating Mycobacterium tuberculosis H37Rv strain infections and with decreased probability of 
developing drug resistance. The synthesis of coumarin derivatives, starting from salicyaldehyde and ethyl acetoacetate, by 
conventional organic reaction and results of investigations of their anti-mycobacterial activity. MICs of the synthesized compounds 
are compared with existing drugs Cytotoxicity. Many compounds have shown promising activity while some were inactive. It was 
found that Compound A1, A2, B1, B2, C1, C2 have shown promising anti tubercular activity against std. Streptomycin 
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INTRODUCTION  
Microbial infections remain the major cause of death 
over the world. Emergence of multi-drug resistant to 
different infectious organisms like M. tuberculosis made 
the condition most alarming. Tuberculosis, MTB, or TB 
is a deadly infectious disease caused by various strains 
of mycobacteria; usually Mycobactеrium tuberculosis. 
According to World Health Organization (WHO) TB is 
a global pandemic, which has become an important 
world-wide public health menace with one-third of the 
world’s population infected by the TB bacillus. Most 
infections do not havе symptoms, known as latеnt 
tubеrculosis and about one in ten latent infеctions 
еvеntually progresses to activе disеasе which, if lеft 
untrеatеd, kills morе than 50% of those so infected. 
Pеoplе with wеak immunе systеms (thosе with 
HIV/AIDS, thosе rеcеiving immunosupprеssivе drugs 
and chеmothеrapy) arе at a greater risk for developing 
TB disease. 
In this research work we had synthesized novel 
heterocyclic compound and evaluated it for 
antituberculer activity which focuses on finding new 
anti mycobacterial agent to treat tuberculosis as well to 
overcome resistance caused by most of drugs. Coumarin 
(2H-Lbenzopyran-2-one) and its derivatives possess a 
wide range of various biological and pharmaceutical 
activities.  They have a wide range of applications as 
antitumor
1, 2
, anti-HIV 
3, 4
, anticoagulant 
5, 6
, 
antimicrobial
7, 8
, antioxidant
9, 10
, and anti-
inflammatory
11, 12
 agents. The antitumor activities of 
coumarin compounds have been extensively 
examined
13–16
. Although most of the existing natural 
coumarins have been isolated from higher plants, some 
of them have been discovered in microorganisms, for 
example, aminocoumarin antibiotics: novobiocin, 
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coumermycin A1, and chlorobiocin (produced by the 
actinomycete Streptomyces niveus) 
17
. Synthetic 
coumarin derivatives have been obtained by chemical 
modification of the coumarin ring. Recently, density 
functional theory (DFT) has been accepted by the 
quantum chemistry community as a cost-effective 
approach for the computation of molecular structure, 
vibration frequencies, and energies of chemical 
reactions. Many studies have shown that the molecular 
structures and vibration frequencies calculated by DFT 
methods are more reliable than MP2 methods
18–26
. 
While there is sufficient evidence that DFT provides 
accurate description of the electronic and structural 
properties of solids, interfaces, and small molecules, 
relatively little is known about the symmetric 
performance of DFT applications to their molecular 
associates. 
Structure activity relationships of coumarin derivatives 
have revealed that the presence of substituted amino 
derivatives is an essential feature of their 
pharmacological action. Based on these findings, we try 
to describe the synthesis of some compounds featuring 
different heterocyclic rings fused onto the coumarin 
moiety with the aim of obtaining more potent 
pharmacologically active compounds. The need of new 
antimycobacterial is only because of microorganisms is 
being resistant to the present drugs available in the 
clinical use. Worldwide researchers are trying to 
synthesize new drugs with better pharmacokinetic and 
dynamic activity with less adverse effects. The literature 
survey suggests that coumarins have proved to be good 
bioactive molecules, and holds broad potential for 
various activities like anti-bacterial, anti-fungal, anti-
inflammatory, anti-tubercular, anti-HIV, and anticancer 
agents. In this coumarin derivatives synthesized and 
evaluated for antituberculer activity. Structural 
determination was carried out by Infra Red 
spectroscopy, 
1
H-NMR, and preliminary tests as 
Physical constant determination, TLC, and Elemental 
analysis.  
MATERIALS AND METHODS 
General 
The nucleus and its derivatives were analyzed by 
different ways. The melting points were recorded on 
electrothermal apparatus and are uncorrected. (IR) 
spectra were determined on Bruker IFS-66 FTIR 
(Bruker Bioscience, USA) using Potassium bromide 
(KBr) pallets and wave number (í) was reported in cm-
1.  
1
H NMR spectra on a Bruker Avance 300 MHz 
instrument using DMSO as solvent using TMS as 
internal standard; the chemical shifts (δ) were reported 
in ppm with coupling constants (J) are given in Hz. 
Signal multiplicities were represented by s (singlet), d 
(doublet), t (triplet), ds (double singlet), dd (double 
doublet), m (multiplet) and bs (broad singlet. Elemental 
analysis was performed on a Hera-cus CHN-Rapid 
Analyzer. Analysis indicated by the symbols of the 
elements of functions was within ±0.4% of the 
theoretical values. The purity of the compounds was 
checked on silica gel coated Al plates (Merck). 
1.  Synthesis of 3-acetyl coumarin   
To a cold mixture of Salicylaldehydehyde (0.2M) and 
ethyl acetoacetate (0.2M), 2ml of piperidine was added 
by rapid stirring. After 20 min thee yellowish solid 
separated was filtered off subsequently washed with 
ethanol and was recrystallised from water: ethanol (3:7), 
M.P 120
0
 C and yield was 83.6%. 
2. Preparation of 3-aryl-1-(3-coumarinyl) propan-1-
ones:  
A mixture of 3-acetyl coumarin and various substituted 
aldehydes(0.012 M) were dissolved in 10ml of n- 
butanol under heating; then 0.3ml glacial acetic acid and 
the same quantity of piperidine were added. The 
reaction mixture was refluxed for 4 hours and then 
solvent was removed in vacuum. The residue was 
triturated with 10ml ethanol until a precipitate formed. 
The precipitate was filtered off and recrystallized from 
appropriate solvent.  
3. Synthesis of 5-(substituted) aryl-3-(3-coumarinyl)-
1-phenyl-2- pyrazoline  
3-aryl-1-(3-coumarinyl) -1-propan-1-ones, 0.05M and 
phenyl hydrazine (0.2M) were dissolved in pyridine 
(30ml) and refluxed for 6hrs. Reaction mixture was 
poured on to the crushed ice and neutralized with 2N 
hydrochloric acid. The precipitated solid was filtered, 
dried and recrystallised from appropriate solvent to 
afford the title compound. 
Spectral Data 
A1- IR (KBr): 3650(Secondary amine), 3150 (C=C str), 
3016 (Aromatic CH), 1950-1450 (Double bonded 
functional group), 1706 (CO str), 1639 (CN str), 1410 
(Co str), 3000 (NH bending), 1250 (NH bending), 
NMR:  10.0-10.1 1H, (NH, Pri. amine), 8.8-8.9 4H, 
(CH, Pyridine), 7.8-7.9 5H, (CH, Benzene), 4.6-4.8 1H,   
(NH, Sec. amine) 
A2- IR (KBr): 3645(Secondary amine), 3150 (C=C str), 
3016 (Aromatic CH), 1950-1450 (Double bonded 
functional group), 1700 (CO str), 1620 (CN str), 1410 
(Co str), 1400 (SO2 bending), 3000 (NH bending), 1250 
(NH bending) 
A3- IR (KBr): 3650(Secondary amine), 3150 (C=C str), 
3010 (Aromatic CH), 1950-1450 (Double bonded 
functional group), 1706 (CO str), 1639 (CN str), 1410 
(Co str), 3000 (NH bending), 1250 (NH bending) 
B1- IR (KBr): 3650(Secondary amine), 3150 (C=C str), 
3016 (Aromatic CH), 1950-1450 (Double bonded 
functional group), 1706 (CO str), 1639 (CN str), 1410 
(Co str), 3000 (NH bending), 1250 (NH bending) 
B2- IR (KBr): 3650(Secondary amine), 3150 (C=C str), 
3016 (Aromatic CH), 1950-1450 (Double bonded 
functional group), 1706 (CO str), 1639 (CN str), 1410 
(Co str), 1400 (SO2 bending ),3000 (NH bending), 1250 
(NH bending) 
B3- IR (KBr): 3650(Secondary amine), 3150 (C=C str), 
3016 (Aromatic CH), 1950-1450 (Double bonded 
functional group), 1706 (CO str), 1639 (CN str), 1410 
(Co str), 3000 (NH bending), 1250 (NH bending) 
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C1- IR (KBr): 3650(Secondary amine), 3150 (C=C str), 
3016 (Aromatic CH), 1950-1450 (Double bonded 
functional group), 1706 (CO str), 1639 (CN str), 1410 
(Co str), 3000 (NH bending), 1250 (NH bending) 
NMR:  10.0-10.1 1H, (NH, Pri. amine), 8.8-8.9 4H, 
(CH, Pyridine), 7.8-7.9 5H, (CH, Benzene), 4.6-4.8 1H,   
(NH, Sec. amine) 
C2- IR (KBr): 3650(Secondary amine), 3150 (C=C str), 
3016 (Aromatic CH), 1950-1450 (Double bonded 
functional group), 1706 (CO str), 1639 (CN str), 1410 
(Co str), 1400 (SO2 bending) 3000 (NH bending), 1250 
(NH bending) 
C3- IR (KBr): 3650(Secondary amine), 3150 (C=C str), 
3016 (Aromatic CH), 1950-1450 (Double bonded 
functional group), 1706 (CO str), 1639 (CN str), 1410 
(Co str), 3000 (NH bending), 1250 (NH bending) 
Antituberculer activity: 
The compounds were tested in-vitro for their 
antituberculer activity against H37Rv Strain.  
Method: 
Alamar Blue Dye 
The antitubercular screening was carried out by Middle 
brook 7H9 agar medium against H37Rv Strain. Middle 
brook 7H9 agar medium was inoculated with 
Mycobacterium tuberculosis of H37Rv Strain. The 
inoculated bottles were incubated for 37C for 4 weeks. 
At the end of 4 weeks they were checked for growth.
 
 
RESULT 
Scheme: (A1-A3, B1-B3, C1-C3) 
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Table 1: Derivatives 
Compound R Ar 
A1  
 
 
 
 
 
A2  
 
 
A3  
 
B1  
 
 
 
B2  
 
B3  
 
C1  
 
 
 
 
 
C2  
 
C3  
 
 
Table 2: Analytical data of the compound 
Comp. Mol. formula Mol. wt Melting 
Point (
0
C) 
Rf  
Value  
Yield 
% 
Elemental analysis Calculated 
C H N O S 
A1 C27H19N3O5 465.45 198-200 0.57 84.67 69.67 4.11 9.03 17.19  
A2  C26H19N5O4  465.46  175-177 0.69 82.77 67.09  4.11  15.05  13.75   
A3  C26H20N4O5S  500.52  167-169 0.62 77.19 62.39  4.03  11.19  15.98  6.41  
B1  C27H19N3O6  481.45  199-202  0.55 71.57 67.36  3.98  8.73  19.94   
B2  C26H19N5O5  481.45  202-204 0.78 81.29 64.86  3.98  14.55  16.62   
B3  C26H20N4O5S  500.52  273-275 0.75 84.23 62.39  4.03  11.19  15.98  6.41  
C1  C29H21N3O5  491.49  198-200  0.8 79.83 70.87  4.31  8.55  16.28   
C2  C28H21N5O4  491.49  195-198  0.64 82.91 68.42  4.31  14.25  13.02   
C3  C28H22N4O4S  510.56  198-200 0.57 82.79  65.87  4.34  10.97  12.53  6.28  
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Table 3: Anti-tuberculer activity of 5-(substituted) aryl-3-(3-coumarinyl)-1-phenyl-2- pyrazoline compounds 
 
 
Figure 1: IR Spectra of A1 
 
Figure 2: NMRSpectra of A1 
Comp ID  100  50  25  12.5  6.25  3.125  1.6  0.8  0.4  0.2  
A1  S  S  S  S  S  S  S  R  R  R  
A2  S  S  S  S  S  S  R  R  R  R  
A3  S  S  S  S  R  R  R  R  R  R  
B1  S  S  S  S  S  S  S  S  R  R  
B2  S  S  S  S  S  S  R  R  R  R  
B3  S  S  S  S  S  R  R  R  R  R  
C1  S  S  S  S  S  S  S  R  R  R  
C2  S  S  S  S  S  S  R  R  R  R  
C3  S  S  S  R  R  R  R  R  R  R  
Streptomycin  S  S  S  S  S  R  R  R  R  R  
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DISCUSSION 
In the present research work, we have synthesized 9 new 
5-(substituted) aryl-3-(3-coumarinyl)-1-phenyl-2- 
pyrazoline derivatives as explained in the scheme. The 
purity of the compounds was checked by TLC and 
melting point. Structures of these compounds were 
confirmed by IR, 1HNMR and elemental analysis. The 
synthesized compounds were subjected to anti tubercular 
activity by Alamar Blue Dye method against the 
standard streptomycin. 
Compound A1, A2, B1, B2, C1, C2 have shown promising 
antitubercular activity against streptomycin at 
concentration of 1.6 mcg/ml by interpreting data of 
MIC. With the suitable molecular modification and 
manipulation with possible SAR studies of these 
compounds, promising anti tubercular agents can be 
obtained
26-27
.  
CONCLUSION 
The practice of medicinal chemistry is devoted to 
discovery and development of new agents for treating 
diseases. Most of the activity in this discipline is 
directed to new natural or synthetic organic compounds. 
Heterocyclic compounds have a major place in therapy 
and they being increasingly specific biological and 
pharmacological activities are clearly the dominant 
force. Thousands of heterocyclic compounds are 
prepared annually throughout the world, and many of 
them enter into pharmacological screening to determine 
if they have useful biological activities.   
The present work proposed to study on design, synthesis 
and biological evaluation of coumarin heterocycles. 
Around nine compounds were synthesized by 
conventional and efficient method. The detailed review 
of literature and survey was carried out for the synthesis 
of coumarin derivatives for antituberculer activity. A 
series of 5-(substituted) aryl-3-(3-coumarinyl)-1-phenyl-
2- pyrazoline (A1-C3) were designed and synthesized.   
The purity of synthesized compounds was ascertained by 
TLC. Melting points were determined by open capillary 
method and are uncorrected. The structures of the 
synthesized compounds were confirmed on the basis of 
elemental analysis and spectral studies detailed below. 
1. IR spectra were recorded on JASCO-420-FTIR 
spectrometer by KBr pellet technique. 
2. 1H-NMR spectra were recorded on Bruker Avance 
II 400 NMR spectrometer. 
The compounds were subjected to selected biological 
and pharmacological activities. The synthesized 
compounds were screened for the antituberculer activity 
against streptomycin between concentration ranges of 
2μg/ml - 100μg/ml by Alarm blue method. Most of the 
compounds were active against selected microorganisms 
and inhibited the growth.  
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